Unitedhealth Group Inc (NYSE:UNH) shares traded -5.21% lower at $578.97 on Wall Street last session.
UNH stock price is now -1.33% away from the 50-day moving average and 7.71% away from the 200-day moving average. The market capitalization of the company currently stands at $532.82B.
On October 11, 2024, KeyBanc Capital Markets recently initiated its ‘Overweight’ rating on the stock quoting a target price of $675, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, McSweeney Erin, EVP & Chief People Officer sold 701 shares of the company’s stock on Nov 11 ’24. The stock was sold for $438,987 at an average price of $626.23. Upon completion of the transaction, the EVP & Chief People Officer now directly owns 7,105 shares in the company, valued at $4.11 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 11 ’24, Officer McSweeney Erin bought 701 shares of the business’s stock. A total of $438,987 was incurred on buying the stock at an average price of $626.23. A total of 0.23% of the company’s stock is owned by insiders.
During the past 12 months, Unitedhealth Group Inc has had a low of $436.38 and a high of $630.73. According to the stock market information, the enterprise value for the company is $583613022208, which is based on a 37.61 price-to-earnings ratio, a 2.89 price-to-earnings-growth ratio, and a beta of 0.59. The fifty day moving average price for UNH is $586.7378 and a two-hundred day moving average price translates $537.21954 for the stock.
The latest earnings results from Unitedhealth Group Inc (NYSE: UNH) was released for 2024-09-30. The net profit margin was 3.65% and return on equity was 15.99% for UNH. The company reported revenue of $100.82 billion for the quarter, compared to $92.36 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.16 percent.
